Gene-editing technology is moving from the research lab to the clinic, one of the most eagerly anticipated biopharma developments in recent history. One of the biggest hurdles to the development of successful gene-editing therapeutics is effective delivery of the large and sensitive components needed to execute the editing functions. Lipid-based nanoparticles present promising solutions to these challenges.
Lipid-based therapeutic delivery systems have been evolving for many years. From delivering naked mRNA, to using liposomes, and now lipid nanoparticles, Avanti is here to provide you with the most innovative lipids for your nucleic acid delivery research. In this article discover considerations for each component in an LNP, as well as some new alternatives to commonly used LNP components such as PEG-lipids and cholesterol.
Avanti is at the forefront of lipid-based delivery systems technology and our lipids are being used in research for various theranostic approaches. Keep reading to find out what types of diseases our lipids are being used to diagnose and treat!
We are delighted to share another Lipid Nanoparticle (LNP) Technology highlight! In this week's article, we take a look a closer look at microfluidics! Keep reading to learn more!
We are delighted to share another Lipid Nanoparticle (LNP) Technology highlight! In this week's article, we take a look at research that might help you decide the best way to manufacture you lipid nanoparticles! Keep reading to learn more!
Continuing on our theme of Lipid Nanoparticle (LNP) Technology, did you know that cationic liposomes are being evaluated in theranostic applications? That is exactly what researchers at the Technical University of Denmark and the University of Copenhagen have been investigating. Keep reading to learn more!
This month's blog theme is Lipid Nanoparticle (LNP) Technology, and we’re going to kick it off with an article showing the effectiveness of LNPs in theranostics! Keep reading to learn more about this exciting field!
